Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
49
NCT02498535
Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 22, 2017
Completion: Jun 1, 2020